Literature DB >> 4141778

Autoimmunity and lymphoid malignancy in New Zealand black mice.

N Talal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4141778

Source DB:  PubMed          Journal:  Prog Clin Immunol        ISSN： 0090-3310


× No keyword cloud information.
  7 in total

1.  Selective bone marrow involvement of lymphoplasmacytic cells secreting monoclonal IgA rheumatoid factor in a patient with Sjögren's syndrome and serum hyperviscosity.

Authors:  C Bergonzi; G P Merlini; S Morandi; E Bianchini; F Pavesi; V Bellotti; C M Montecucco; E Ascari
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

2.  Monoclonal gammopathies in Japanese patients with Sjögren's syndrome.

Authors:  S Sugai; S Shimizu; Y Hirose; T Takiguchi; S Konda; H Yamano
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

3.  Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome).

Authors:  U Schmid; D Helbron; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

4.  Immunologic regulation of spontaneous antibodies to DNA and RNA I. Significance of IgM and IgG antibodies in SLE patients and asymptomatic relatives.

Authors:  N Talal; R J Pillarisetty; R J DeHoratius; R P Messner
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

5.  Antibodies binding polyriboadenylic acid in systemic lupus erythematosus. Immunochemical characterization and isolation by affinity chromatography.

Authors:  R J Pillarisetty; M J Becker; D W Palmer; N Talal
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

6.  Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.

Authors:  J Naparstek; M Eliakim
Journal:  Am J Dig Dis       Date:  1978-10

7.  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.

Authors:  Z M Sthoeger; M Wakai; D B Tse; V P Vinciguerra; S L Allen; D R Budman; S M Lichtman; P Schulman; L R Weiselberg; N Chiorazzi
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.